• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Hyperparathyroidism in chronic kidney disease: complexities within the commonplace.慢性肾脏病中的甲状旁腺功能亢进症：常见病症中的复杂性。
Clin Med (Lond). 2012 Aug;12(4):333-7. doi: 10.7861/clinmedicine.12-4-333.
2
Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment.慢性肾脏病继发性甲状旁腺功能亢进的治疗结果及直接治疗成本
J Manag Care Pharm. 2007 Jun;13(5):397-411. doi: 10.18553/jmcp.2007.13.5.397.
3
Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease.3期和4期慢性肾脏病继发性甲状旁腺功能亢进的管理
Endocr Pract. 2008 Jan-Feb;14(1):18-27. doi: 10.4158/EP.14.1.18.
4
Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.慢性血液透析患者继发性甲状旁腺功能亢进治疗方法的近期变化及其与预后的关系：透析预后与实践模式研究（DOPPS）
Clin J Am Soc Nephrol. 2015 Jan 7;10(1):98-109. doi: 10.2215/CJN.12941213. Epub 2014 Dec 16.
5
Secondary hyperparathyroidism among Nigerians with chronic kidney disease.尼日利亚慢性肾脏病患者中的继发性甲状旁腺功能亢进
Afr Health Sci. 2018 Jun;18(2):446-457. doi: 10.4314/ahs.v18i2.30.
6
Comparison between calcitriol and calcitriol plus low-dose cinacalcet for the treatment of moderate to severe secondary hyperparathyroidism in chronic dialysis patients.比较骨化三醇与骨化三醇加小剂量西那卡塞治疗慢性透析患者中重度继发性甲状旁腺功能亢进症。
Nutrients. 2013 Apr 19;5(4):1336-48. doi: 10.3390/nu5041336.
7
Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney disease.盐酸西那卡塞：治疗5期慢性肾脏病继发性甲状旁腺功能亢进的新疗法。
Kidney Int Suppl. 2005 Jul(96):S24-8. doi: 10.1111/j.1523-1755.2005.00451.x.
8
Paricalcitol and cinacalcet have disparate actions on parathyroid oxyphil cell content in patients with chronic kidney disease.帕立骨化醇和西那卡塞对慢性肾脏病患者甲状旁腺嗜酸细胞含量有不同的作用。
Kidney Int. 2017 Nov;92(5):1217-1222. doi: 10.1016/j.kint.2017.05.003. Epub 2017 Jul 24.
9
Management of secondary hyperparathyroidism in the elderly patient with chronic kidney disease.老年慢性肾脏病患者继发性甲状旁腺功能亢进的管理
Drugs Aging. 2009;26(6):457-68. doi: 10.2165/00002512-200926060-00002.
10
Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet.用拟钙剂西那卡塞治疗肾移植患者因难治性甲状旁腺功能亢进导致的严重高钙血症。
Clin Nephrol. 2006 May;65(5):374-7. doi: 10.5414/cnp65374.

引用本文的文献

1
Single-cell RNA sequencing reveals the role of cell heterogeneity in the sex difference in primary hyperparathyroidism.单细胞 RNA 测序揭示了细胞异质性在原发性甲状旁腺功能亢进性别差异中的作用。
Front Endocrinol (Lausanne). 2023 Mar 7;14:1165890. doi: 10.3389/fendo.2023.1165890. eCollection 2023.

本文引用的文献

1
Chapter 4.1: Treatment of CKD-MBD targeted at lowering high serum phosphorus and maintaining serum calcium.第4.1章：针对降低高血清磷和维持血清钙水平的慢性肾脏病-矿物质和骨异常的治疗
Kidney Int. 2009 Aug;76113:S50-99. doi: 10.1038/ki.2009.192.
2
Chapter 3.1: Diagnosis of CKD-MBD: biochemical abnormalities.第3.1章：慢性肾脏病-矿物质和骨异常的诊断：生化异常
Kidney Int. 2009 Aug;76113:S22-49. doi: 10.1038/ki.2009.191.
3
Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets.正常个体和低钙及高钙饮食慢性肾脏病患者的钙平衡。
Kidney Int. 2012 Jun;81(11):1116-22. doi: 10.1038/ki.2011.490. Epub 2012 Feb 1.
4
Familial hypocalciuric hypercalcaemia: a review.家族性低钙尿性高钙血症：综述。
Curr Opin Endocrinol Diabetes Obes. 2011 Dec;18(6):359-70. doi: 10.1097/MED.0b013e32834c3c7c.
5
Use of ultrasound to assess the response to therapy for secondary hyperparathyroidism.使用超声评估继发性甲状旁腺功能亢进症治疗反应。
Am J Kidney Dis. 2011 Sep;58(3):485-91. doi: 10.1053/j.ajkd.2011.03.030. Epub 2011 Jun 29.
6
The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease.尿调蛋白（Tamm-Horsfall 蛋白）的再发现：从肾小管间质性肾病到慢性肾脏病。
Kidney Int. 2011 Aug;80(4):338-47. doi: 10.1038/ki.2011.134. Epub 2011 Jun 8.
7
Parathyroid imaging.甲状旁腺成像。
Radiol Clin North Am. 2011 May;49(3):489-509, vi. doi: 10.1016/j.rcl.2011.02.009.
8
Instability of fibroblast growth factor-23 (FGF-23): implications for clinical studies.成纤维细胞生长因子 23（FGF-23）的不稳定性：对临床研究的影响。
Clin Chim Acta. 2011 May 12;412(11-12):1008-11. doi: 10.1016/j.cca.2011.02.009. Epub 2011 Feb 12.
9
Utility of the urine calcium-to-creatinine ratio to diagnose primary hyperparathyroidism in asymptomatic hypercalcaemic patients with vitamin D deficiency.尿钙/肌酐比值在维生素 D 缺乏的无症状高钙血症患者中诊断原发性甲状旁腺功能亢进症的作用。
Ann Clin Biochem. 2011 Mar;48(Pt 2):126-9. doi: 10.1258/acb.2010.010202. Epub 2011 Feb 8.
10
Renal allograft failure in a hyperparathyroid patient following initiation of a calcimimetic.甲状旁腺功能亢进患者在使用拟钙剂后发生肾移植失败。
Nat Rev Nephrol. 2011 Apr;7(4):237-41. doi: 10.1038/nrneph.2010.169. Epub 2010 Dec 14.

慢性肾脏病中的甲状旁腺功能亢进症：常见病症中的复杂性。

Hyperparathyroidism in chronic kidney disease: complexities within the commonplace.

机构信息

Department of Renal Medicine, Eastern Health Clinical School, Monash University, Melbourne, Australia.

出版信息

Clin Med (Lond). 2012 Aug;12(4):333-7. doi: 10.7861/clinmedicine.12-4-333.

DOI:10.7861/clinmedicine.12-4-333
PMID:22930877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4952121/
Abstract

Secondary hyperparathyroidism in patients with chronic kidney disease (CKD) is common and usually caused by associated metabolic abnormalities, in particular, hypocalcaemia and hyperphosphataemia. Nevertheless, other causes of hyperparathyroidism can exist concurrently with CKD, challenging diagnostic interpretation and therapeutic intervention. We present four cases of hyperparathyroidism in patients with CKD that highlight some of these dilemmas.

摘要

慢性肾脏病（CKD）患者的继发性甲状旁腺功能亢进症很常见，通常是由代谢异常引起的，特别是低钙血症和高磷血症。然而，其他导致甲状旁腺功能亢进的原因也可能与 CKD 同时存在，这给诊断解读和治疗干预带来了挑战。我们报告了 4 例 CKD 患者的甲状旁腺功能亢进症病例，这些病例突出了其中的一些困境。